Camp4 Therapeutics (CAMP) Assets Average (2024 - 2026)
Camp4 Therapeutics (CAMP) reported Assets Average of $111.6 million for Q1 2026, up 58.25% on a YoY basis from $70.5 million in Q1 2025, and up 9.33% sequentially from $102.1 million in Q4 2025.
Camp4 Therapeutics (CAMP) Assets Average (2024 - 2026) Analysis & Trends
Camp4 Therapeutics (CAMP) has 3 years of Assets Average data on file, last reported at $111.6 million in Q1 2026.
- For the quarter ending Q1 2026, Assets Average rose 58.25% year-over-year to $111.6 million; the trailing twelve-month figure through Mar 2026 stood at $111.6 million (up 58.25% YoY), and the FY2025 full-year result was $98.1 million, up 47.17% from the prior year.
- Assets Average grew to $111.6 million in Q1 2026, from $102.1 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $111.6 million in Q1 2026 to a low of $49.8 million in Q4 2024.
- A 3-year average of $76.7 million and a median of $69.7 million in 2025 frame the typical range for Assets Average.
- Across the five-year window, Assets Average soared 104.88% in 2025 and surged 58.25% in 2026, its largest moves.
- Tracing CAMP's Assets Average over 3 years: stood at $49.8 million in 2024, then jumped by 104.88% to $102.1 million in 2025, then grew by 9.33% to $111.6 million in 2026.
- Business Quant data shows CAMP's Assets Average at $111.6 million in Q1 2026, $102.1 million in Q4 2025, and $68.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 65.01 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.37 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 41.64 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.30 Bn |
| 10 | Camp4 Therapeutics | 174.35 Mn | 174.35 Mn | - | 111.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 111.63 Mn |
| Dec 31, 2025 | 102.10 Mn |
| Sep 30, 2025 | 68.84 Mn |
| Jun 30, 2025 | 57.02 Mn |
| Mar 31, 2025 | 70.54 Mn |
| Dec 31, 2024 | 49.84 Mn |